Loading…
Loading…
See exactly how PSC's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for PSC and 80,000+ other tickers.
The primary goal of this fund is to generate substantial long-term capital appreciation. Typically, the fund commits a significant majority—at least 80%—of its total investable capital (including any funds borrowed for investment) to purchasing stocks of American companies. These are companies characterized by small market capitalizations at the point of initial acquisition.
Mirum Pharmaceuticals, Inc. (Nasdaq:MIRM) and Incyte (Nasdaq:INCY) today announced pivotal Phase 2 results from Cohort 1 of the PROGRESS study evaluating zilur
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) and Incyte (Nasdaq: INCY) today announced that pivotal Phase 2 results from the PROGRESS study evaluating zilurgiser
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced new data from its rare liver disease programs. Late-breaking result
Rate decrease will be effective beginning next month; Total annual savings for all customers of approximately $285 million ATLANTA, May 28, 2026 /PRNewswire/ -- The Georgia Public Service Commission (PSC) today approved a plan to lower overall rates for customers and deliver annual savings of approximately $50 per year, or $4.04 per month, for the typical residential customer using an average of 1,000 kilowatt-hours a month. Total annual savings for all Georgia Power customers will amount to approximately $285 million.
New stipulated agreement offers $285 million in annual savings for Georgia Power customers starting this summer PR Newswire